GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick relief and daily control.

Please provide your email address to receive an email when new articles are posted on . Risk for first moderate/severe COPD exacerbation was lower among dry powder vs. metered-dose or soft mist ...

What low-GWP propellants mean for inhaler design, manufacturing, and packaging.

TPU researchers, as part of a scientific collaboration, have developed a spatial model that allows us to reliably predict how ...

Severe childhood asthma remains a major challenge in low- and middle-income countries. Find out more about treatment gaps and ...

Thank you for standing by and welcome to the MediPharm Labs conference call to discuss its 2025 full year and fourth quarter results. Our speaker on today's call is Greg Hunter, Chief Financial ...

Detailed price information for Medipharm Labs Corp (MEDIF) from The Globe and Mail including charting and trades.

LAGOS – Urbanisation, environmental changes, and lifestyle modifications in low- and middle-income countries are driving a sharp rise in allergy rates across Africa, while barriers to accessing ...

FY 2025 revenue of $45.1 million, an increase of 8% over 2024International Medical Cannabis revenue increased 43% year-over-year and represented more than 50% of total revenueIncreased cash balance of ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm Adherium, ...

Zyn nicotine pouches are FDA-authorized but can pose health risks. A doctor breaks down 7 risks from gum damage to heart ...